Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Vigil Neuroscience, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +1 vs. Q3 2023
- Shares held
- 25.0M
- −581.0K (−2.3%) vs. Q3 2023
- Total value
- $84.4M
- −$53.3M (−38.7%) vs. Q3 2023
- New holders
- 7
- 15 more added
- Sold out
- 6
- 12 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 2 | $4.55K |
| Q2 2025 | 78 | $265.8M |
| Q1 2025 | 50 | $44.5M |
| Q4 2024 | 51 | $38.4M |
| Q3 2024 | 52 | $94.2M |
| Q2 2024 | 58 | $104.5M |
| Q1 2024 | 54 | $90.5M |
| Q4 2023 | 46 | $84.4M |
| Q3 2023 | 45 | $137.7M |
| Q2 2023 | 47 | $242.1M |
| Q1 2023 | 41 | $245.4M |
| Q4 2022 | 37 | $312.3M |
| Q3 2022 | 33 | $222.7M |
| Q2 2022 | 35 | $44.6M |
| Q1 2022 | 47 | $125.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Vigil Neuroscience, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ameritas Investment Partners, Inc. | 1,327 | $4.49K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,402 | $5.00K | 0.00% | −161−10.3% | Reduced |
| Legal & General Group Plc | 1,554 | $5.27K | 0.00% | 00.0% | Unchanged |
| California State Teachers Retirement System | 2,645 | $8.94K | 0.00% | −901−25.4% | Reduced |
| Tower Research Capital LLC (TRC) | 2,883 | $9.74K | 0.00% | +532+22.6% | Added |
| Royal Bank of Canada | 4,287 | $15.0K | 0.00% | +468+12.3% | Added |
| Wells Fargo & Company | 4,926 | $16.6K | 0.00% | +974+24.6% | Added |
| American International Group, Inc. | 7,987 | $27.0K | 0.00% | −32−0.4% | Reduced |
| STRS Ohio | 8,200 | $27.0K | 0.00% | +8,200 | New |
| New York State Common Retirement Fund | 10,140 | $34.3K | 0.00% | −25−0.2% | Reduced |
| Jane Street Group, LLC | 10,178 | $34.4K | 0.00% | +10,178 | New |
| JPMorgan Chase & Co | 10,415 | $35.2K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 15,728 | $53.2K | 0.00% | +15,728 | New |
| Rhumbline Advisers | 17,269 | $58.4K | 0.00% | −779−4.3% | Reduced |
| Nuveen Asset Management, LLC | 26,840 | $90.7K | 0.00% | +2,125+8.6% | Added |
| Bank of America Corp | 29,034 | $98.1K | 0.00% | +5,433+23.0% | Added |
| PEAK6 Investments LLC | 41,486 | $140.2K | 0.01% | +17,690+74.3% | Added |
| Charles Schwab Investment Management Inc | 41,968 | $141.9K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 48,488 | $163.9K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 54,914 | $185.6K | 0.00% | +42,555+344.3% | Added |
| Citigroup Inc | 66,652 | $225.3K | 0.00% | +2,349+3.7% | Added |
| DAFNA Capital Management LLC | 71,815 | $242.7K | 0.06% | −100,493−58.3% | Reduced |
| Goldman Sachs Group Inc | 85,100 | $287.6K | 0.00% | −61,102−41.8% | Reduced |
| Barclays PLC | 123,795 | $418.4K | 0.00% | +19,205+18.4% | Added |
| Bridgeway Capital Management, LLC | 132,964 | $449.4K | 0.01% | +132,964 | New |
| FMR LLC | 140,834 | $476.0K | 0.00% | −248−0.2% | Reduced |
| Northern Trust Corp | 141,401 | $477.9K | 0.00% | +15,667+12.5% | Added |
| Trustees of Columbia University in the City of New York | 192,973 | $652.2K | 1.38% | 00.0% | Unchanged |
| Anson Funds Management LP | 207,016 | $699.7K | 0.14% | +207,016 | New |
| Ensign Peak Advisors, Inc | 228,674 | $772.9K | 0.00% | +216,750+1,817.8% | Added |
| State Street Corp | 283,291 | $957.5K | 0.00% | +5,678+2.0% | Added |
| ArrowMark Colorado Holdings LLC | 289,460 | $978.4K | 0.01% | +289,460 | New |
| Geode Capital Management, LLC | 315,538 | $1.07M | 0.00% | +10,363+3.4% | Added |
| OrbiMed Advisors LLC | 448,891 | $1.52M | 0.03% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 471,958 | $1.60M | 0.04% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 535,120 | $1.81M | 0.34% | +535,120 | New |
| Pivotal bioVenture Partners Investment Advisor LLC | 560,595 | $1.89M | 0.48% | 00.0% | Unchanged |
| Vanguard Group Inc | 799,197 | $2.70M | 0.00% | +5,231+0.7% | Added |
| BlackRock Inc. | 919,132 | $3.11M | 0.00% | +71,853+8.5% | Added |
| Deerfield Management Company, L.P. (Series C) | 1,173,523 | $3.97M | 0.07% | −653,877−35.8% | Reduced |
| Deep Track Capital, LP | 1,594,931 | $5.39M | 0.19% | −172,200−9.7% | Reduced |
| Artal Group S.A. | 1,811,191 | $6.12M | 0.21% | −96,944−5.1% | Reduced |
| BVF Inc | 1,813,633 | $6.13M | 0.15% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,161,902 | $7.31M | 0.01% | −4,211−0.2% | Reduced |
| Northpond Ventures, LLC | 4,214,498 | $14.2M | 67.78% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 5,836,874 | $19.7M | 2.35% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −616,786−100.0% | Sold out |
| Harvard Management Co Inc | 0 | $0 | 0.00% | −289,460−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −188,390−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −10,839−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −34−100.0% | Sold out |